These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 36341878)

  • 1. Genotoxicity assessment of per- and polyfluoroalkyl substances mixtures in human liver cells (HepG2).
    Ojo AF; Peng C; Ng JC
    Toxicology; 2022 Dec; 482():153359. PubMed ID: 36341878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the individual and combined toxicity of perfluoroalkyl substances to human liver cells using biomarkers of oxidative stress.
    Ojo AF; Xia Q; Peng C; Ng JC
    Chemosphere; 2021 Oct; 281():130808. PubMed ID: 34022600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effects and toxicological interactions of perfluoroalkyl and polyfluoroalkyl substances mixtures in human liver cells (HepG2).
    Ojo AF; Peng C; Ng JC
    Environ Pollut; 2020 Aug; 263(Pt B):114182. PubMed ID: 32247900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
    Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
    Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicological Response of Chironomus dilutus in Single-Chemical and Binary Mixture Exposure Experiments with 6 Perfluoralkyl Substances.
    McCarthy CJ; Roark SA; Wright D; O'Neal K; Muckey B; Stanaway M; Rewerts JN; Field JA; Anderson TA; Salice CJ
    Environ Toxicol Chem; 2021 Aug; 40(8):2319-2333. PubMed ID: 33835531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of legacy and novel perfluoroalkyl substances on human cytochrome P450: An in vitro study on the inhibitory potential and underlying mechanisms.
    Amstutz VH; Cengo A; Sijm DTHM; Vrolijk MF
    Toxicology; 2022 Feb; 468():153116. PubMed ID: 35121066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perfluoroalkylated substances (PFAS) affect oxidative stress biomarkers in vitro.
    Wielsøe M; Long M; Ghisari M; Bonefeld-Jørgensen EC
    Chemosphere; 2015 Jun; 129():239-45. PubMed ID: 25455676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden.
    Dunder L; Salihovic S; Elmståhl S; Lind PM; Lind L
    J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):748-756. PubMed ID: 36964247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances.
    Crawford L; Halperin SA; Dzierlenga MW; Skidmore B; Linakis MW; Nakagawa S; Longnecker MP
    Environ Int; 2023 Feb; 172():107734. PubMed ID: 36764183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of perfluoroalkyl substances (PFAS) and body composition - A cross-sectional study in a middle-aged population.
    Lind PM; Lind L; Salihovic S; Ahlström H; Michaelsson K; Kullberg J; Strand R
    Environ Res; 2022 Jun; 209():112677. PubMed ID: 35074350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfluoroalkyl acids in pregnant women from Nunavik (Quebec, Canada): Trends in exposure and associations with country foods consumption.
    Caron-Beaudoin É; Ayotte P; Blanchette C; Muckle G; Avard E; Ricard S; Lemire M
    Environ Int; 2020 Dec; 145():106169. PubMed ID: 33041046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response to COVID-19 vaccines among workers with a wide range of exposure to per- and polyfluoroalkyl substances.
    Porter AK; Kleinschmidt SE; Andres KL; Reusch CN; Krisko RM; Taiwo OA; Olsen GW; Longnecker MP
    Environ Int; 2022 Nov; 169():107537. PubMed ID: 36183490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Legacy and alternative per- and polyfluoroalkyl substances (PFAS) alter the lipid profile of HepaRG cells.
    Kashobwe L; Sadrabadi F; Brunken L; Coelho ACMF; Sandanger TM; Braeuning A; Buhrke T; Öberg M; Hamers T; Leonards PEG
    Toxicology; 2024 Aug; 506():153862. PubMed ID: 38866127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfluoroalkyl substances and sex hormones in postmenopausal women: NHANES 2013-2016.
    Wang Y; Aimuzi R; Nian M; Zhang Y; Luo K; Zhang J
    Environ Int; 2021 Apr; 149():106408. PubMed ID: 33548847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between perfluoroalkyl substances concentration and bone mineral density in the US adolescents aged 12-19 years in NHANES 2005-2010.
    Xiong X; Chen B; Wang Z; Ma L; Li S; Gao Y
    Front Endocrinol (Lausanne); 2022; 13():980608. PubMed ID: 36277702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PFAS (per- and polyfluoroalkyl substances) and asthma in young children: NHANES 2013-2014.
    Jackson-Browne MS; Eliot M; Patti M; Spanier AJ; Braun JM
    Int J Hyg Environ Health; 2020 Aug; 229():113565. PubMed ID: 32485600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human biomonitoring of per- and polyfluoroalkyl substances in German blood plasma samples from 1982 to 2019.
    Göckener B; Weber T; Rüdel H; Bücking M; Kolossa-Gehring M
    Environ Int; 2020 Dec; 145():106123. PubMed ID: 32949877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentrations of perfluoroalkyl substances (PFASs) in human embryonic and fetal organs from first, second, and third trimester pregnancies.
    Mamsen LS; Björvang RD; Mucs D; Vinnars MT; Papadogiannakis N; Lindh CH; Andersen CY; Damdimopoulou P
    Environ Int; 2019 Mar; 124():482-492. PubMed ID: 30684806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the cytotoxicity of per- and polyfluoroalkyl substances in HepG2 cells: A structure-activity relationship approach.
    Amstutz VH; Cengo A; Gehres F; Sijm DTHM; Vrolijk MF
    Toxicology; 2022 Oct; 480():153312. PubMed ID: 36075290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.